About Devgen
Devgen is a Healthcare company based in Secunderabad (India) founded in 1997, and was acquired by Syngenta in December 2013. It operates as a hybrid field crop seeds are provided to farmers via biotechnology. It operates in the Healthcare and Agriculture sectors. The company has 2 employees. Its chief executive is Bipin Solanki. Its Indian entity Devgen Seeds And Crop Technology Private Limited reported revenue of ₹71 Lakh. Its focus areas include Food and Agriculture Tech, Crop Tech, Farm Inputs and Seeds. Its competitors include Benson Hill, Cibus, Ceres, Pairwise and Inari and 3 more; 7 of its 8 listed competitors have raised funding.
Company details
Devgen was founded in 1997 in Secunderabad, India, and operates in the agriculture sector. Hybrid seeds for field crops are developed using advanced biotechnology and molecular breeding techniques, with a focus on rice varieties. Nematicides are also produced to protect crops from parasitic nematodes. The product portfolio encompasses hybrid rice, sunflower, sorghum, pearl millet, and cotton seeds.
- Headquarters Secunderabad, India
- Employees 2
- Stage Acquired
- SectorsHealthcareAgriculture
- Website devgen.com
- Social LinkedIn
- Acquired by Syngenta (Dec 2013)
- Legal Name Devgen Seeds And Crop Technology Private Limited
- Date of Incorporation 28 Mar, 2007
- Jurisdiction Hyderabad, Telangana, India
Associated legal entities of Devgen
Devgen operates through Devgen Seeds And Crop Technology Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Devgen Seeds And Crop Technology Private Limited CIN U01117TG2007PTC053372 | Active | 28 Mar 2007 | Hyderabad, Telangana | ₹0.7 Cr | 2 | 2 | View details |
Funding Insights of Devgen
- Total Rounds 4
- Last Round Grant — $50,772
- First Round $24.79M
(Oct 1999)
- Investors Count 9
All 4 funding rounds of Devgen with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2021 | $50,772 | Grant | – | – | |
| Feb 2007 | $40.3M | Post-IPO | – | – | – |
| Jul 2000 | $5.83M | Post-IPO | – | – | |
| Oct 1999 | $24.79M | Post-IPO | – | – |
10 investors in total: 10 institutional.
Investors in Devgen
Devgen has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include Syngenta, KBC Bank & Verzekering and Gimv.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are directed by Capricorn Partners into European tech ventures. | 1993 | capricorn.be | Leuven, Belgium | |
Early stage venture capital firm investing in US | 1973 | abingworth.com | London, United Kingdom | |
Private equity firm focused on multiple sectors | – | adventinternational.com | Sao Paulo, Brazil | |
Private equity firm | 1980 | gimv.com | Antwerp, Belgium | |
Private equity investments in life sciences businesses are managed. | 1998 | lspvc.com | Amsterdam, Netherlands | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Banking and insurance services are provided in Belgium. | 1998 | kbc.be | Brussels, Belgium | |
Boutique investment banking for middle-market M&A and valuations is provided. | – | mercatorcapital.com | Washington, Dc, United States | |
- | – | rendex.io | - | |
Crop protection solutions and hybrid seeds are provided for farming. | 2000 | syngenta.com | Basel, Switzerland |
Investor details for Devgen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Devgen Seeds And Crop Technology Private Limited (Devgen)
Devgen Seeds And Crop Technology Private Limited is the primary company behind Devgen. The board of Devgen Seeds And Crop Technology Private Limited currently have 2 directors; the longest-serving is Sudip Ghosh, appointed in 2018. 15 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sudip Ghosh DIN 08155982 | Director | 15 Jun 2018 | 8 yrs 4 mo | Devgen Seeds And Crop Technology Private Limited |
| Suryarao Rongali DIN 08325828 | Additional Director | 11 Jan 2019 | 7 yrs 9 mo | Devgen Seeds And Crop Technology Private Limited |
People of Devgen
1 people are tracked at Devgen (1 in leadership); the tracked headcount is 2.
| Name | Role | Group |
|---|---|---|
Bipin Solanki | CEO | Leadership |
Complete people profiles for Devgen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Devgen
Figures of Devgen Seeds And Crop Technology Private Limited, the primary company behind Devgen, for FY 2025. Revenue was ₹71 Lakh (+3% year on year). Net loss was -₹3.24 Cr (-456% margin). EBITDA was -₹24 Lakh (-34% margin). Revenue has grown at a compounded annual rate of 0% over three years and -6% over five years.
- ₹71 LakhRevenue · FY 2025 · +3% YoY
- -₹3.24 CrNet loss · -456% margin
- -₹24 LakhEBITDA · -34% margin
- ₹78.35 CrPaid-up capital
- 2Employees (provident fund records)
- 0%Revenue CAGR, 3 years
- -6%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Devgen Seeds And Crop Technology Private Limited are on its company page.
Detailed financial statements for Devgen
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Devgen
4 dated milestones of Devgen across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Devgen is founded.
- Funding First funding round of $24.8M.
- Exit Acquired by Syngenta.
- Funding Latest funding round, Grant, of $51K.
Competitors of Devgen
Devgen has 8 listed competitors in our database, 7 of them funded. They include Benson Hill, Cibus, Ceres, Pairwise and Inari, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bensonhill.com | 2012 | St. Louis, United States | $406.99M | 151 | Provider of plant-based food ingredients | |
| cibus.com | 2001 | San Diego, United States | $34.47M | 129 | Gene editing solutions are provided for agriculture. | |
| ceres.com | 1996 | Milan, Italy | – | – | Beers are produced and branded by Ceres in Italy. | |
| pairwise.com | 2017 | Durham, United States | $155M | – | New crop varieties are developed using gene-editing for agrigenomics. | |
| inari.com | 2016 | Cambridge, United States | $708M | 143 | Breeding technology is provided by Inari to design seeds. | |
| limagrain.com | 1965 | Clermont Ferrand, France | $200M | – | Production and distribution of GM and non-GMO seeds and other farm inputs | |
| nuziveeduseeds.com | 1973 | Hyderabad, India | $104.71M | 1,258 | Improved crop varieties and hybrids are developed and marketed. | |
| renaissancebioscience.com | 2013 | Vancouver, Canada | $5M | 17 | Yeast strains are developed through classical and selective breeding techniques. |
Detailed competitors of Devgen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as Devgen (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Devgen
Devgen was founded in 1997 and raised its 1st funding round 2 years after it was founded.
Devgen is headquartered in Secunderabad, India. It is registered at Secunderabad, Telangana, India.
Bipin Solanki is the current CEO of Devgen.
Devgen has 2 employees.
The primary company behind Devgen, Devgen Seeds And Crop Technology Private Limited, reported revenue of ₹71 Lakh for FY 2025, up 3% year on year.
Devgen was founded in 1997 in Secunderabad, India, and operates in the agriculture sector. Hybrid seeds for field crops are developed using advanced biotechnology and molecular breeding techniques, with a focus on rice varieties. Nematicides are also produced to protect crops from parasitic nematodes. The product portfolio encompasses hybrid rice, sunflower, sorghum, pearl millet, and cotton seeds.
Devgen's top competitors include Benson Hill, Cibus and Inari.
Devgen has 10 investors. Key investors include Syngenta, KBC Bank & Verzekering, Gimv, European Union, and Abingworth.
Devgen operates through Devgen Seeds And Crop Technology Private Limited.
Yes. Devgen was acquired by Syngenta in December 2013.
The legal entities of Devgen currently have 2 directors, including Sudip Ghosh, Suryarao Rongali.